CONCORDANCE OF THE FDA-APPROVED COMPANION DIAGNOSTIC AND A NEXT-GENERATION SEQUENCING ASSAY KIT FOR ASSESSING HOMOLOGOUS RECOMBINATION DEFICIENCY IN OVARIAN CANCER

被引：0
|
作者：
Weichert, W. [1 ]
Qiu, P. [2 ]
Lunceford, J. [2 ]
Wehn, A. [2 ]
Yarunin, A. [3 ]
Marton, M. [2 ]
机构：
[1] Tech Univ Munich, Inst Pathol, Munich, Germany
[2] Merck & Co Inc, Kenilworth, NJ USA
[3] AstraZeneca, Alderley Pk, England
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2021年 / 31卷
关键词：
D O I：
10.1136/ijgc-2021-ESGO.665
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
978
引用
收藏
页码：A375 / A375
页数：1
相关论文
共 41 条
  • [21] FDA-APPROVED NEXT-GENERATION SEQUENCING SYSTEM COULD EXPAND CLINICAL GENOMIC TESTING Experts predict MiSeqDx platform will make genetic testing more affordable for smaller labs
    不详
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2014, 164 (03) : X - XI
  • [22] Detection of germline homologous recombination deficiency (HRD) in patients with metastatic esophagogastric (EG) cancer using clinical next generation sequencing (NGS).
    Janjigian, Yelena Yuriy
    Jonsson, Philip
    Kemel, Yelena
    Joseph, Vijai
    Tuvy, Yaelle
    Shameer, Zarina
    Ravichandran, Vignesh
    Zhang, Liying
    Mandelker, Diana
    Ku, Geoffrey Yuyat
    Hechtman, Jaclyn Frances
    Kelsen, David Paul
    Ilson, David H.
    Offit, Kenneth
    Berger, Michael F.
    Schultz, Nikolaus
    Robson, Mark E.
    Solit, David B.
    Taylor, Barry S.
    Stadler, Zsofia Kinga
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [23] Evaluation of homologous recombination repair (HRR) status in metastatic prostate cancer by next-generation sequencing and functional tissue-based immunofluorescence assays
    Morgado, Pablo Cresta
    Arce-Gallego, Sara
    Delgado-Serrano, Luisa
    Simonetti, Sara
    Gonzalez, Macarena
    Castaneda, David Humberto Marmolejo
    Morales-Barrera, Rafael
    Planas, Jacques
    Romero-Lozano, Paula
    Maldonado, Xavier
    Suarez, Cristina
    Figols, Mariona
    Cros, Sara
    Dienstmann, Rodrigo
    Nuciforo, Paolo
    Vivancos, Ana
    Llop-Guevara, Alba
    Carles, Joan
    Serra, Violeta
    Mateo, Joaquin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [24] Clinical relevance of double heterozygosity revealed by next-generation sequencing of homologous recombination repair pathway genes in South African breast cancer patients
    van der Merwe, Nerina C.
    Buccimazza, Ines
    Rossouw, Bianca
    Araujo, Monica
    Ntaita, Kholiwe S.
    Schoeman, Mardelle
    Vorster, Karin
    Napo, Kgabo
    Kotze, Maritha J.
    Oosthuizen, Jaco
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 207 (02) : 331 - 342
  • [25] Homologous Recombination Deficiency (HRD) Phenotype Assessment Using Chromosomal Microarray (CMA) and 523-Gene Next-Generation Sequencing (NGS) Panel: A Comparative Analysis
    Vashisht, A.
    Kolhe, R.
    Mondal, A.
    Ahluwalia, P.
    Singh, H.
    Omar, N.
    Alptekin, A.
    Vashisht, V.
    Gupta, V.
    Williams, C.
    Srinivas, A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2023, 25 (11): : S160 - S160
  • [26] Next-generation sequencing of homologous recombination genes could predict efficacy of platinum-based chemotherapy in non-small cell lung cancer
    Zhang, Linlin
    Guan, Shasha
    Meng, Fanlu
    Teng, Lin
    Zhong, Diansheng
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [27] Comparative Analysis of Chromosomal Microarray (CMA) and 505-Gene Next-Generation Sequencing (NGS) Panel for Homologous Recombination Deficiency (HRD) Phenotype Assessment in Solid Tumors
    Vashisht, A.
    Kolhe, R.
    Mondal, A.
    Ahluwalia, P.
    Singh, H.
    Omar, N.
    Alptekin, A.
    VashishT, V.
    Gupta, V.
    Williams, C.
    Srinivas, A.
    Jackson, J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2023, 25 (11): : S138 - S138
  • [28] Next-generation sequencing-based BRCA testing on cytological specimens from ovarian cancer ascites reveals high concordance with tumour tissue analysis
    Fumagalli, Caterina
    Rappa, Alessandra
    Casadio, Chiara
    Betella, Ilaria
    Colombo, Nicoletta
    Barberis, Massimo
    Guerini-Rocco, Elena
    JOURNAL OF CLINICAL PATHOLOGY, 2020, 73 (03) : 168 - 171
  • [29] Next-Generation Sequencing on Circulating Tumor DNA in Advanced Solid Cancer: Swiss Army Knife for the Molecular Tumor Board? A Review of the Literature Focused on FDA Approved Test
    Vasseur, Damien
    Sassi, Hela
    Bayle, Arnaud
    Tagliamento, Marco
    Besse, Benjamin
    Marzac, Christophe
    Arbab, Ahmadreza
    Auger, Nathalie
    Cotteret, Sophie
    Aldea, Mihaela
    Blanc-Durand, Felix
    Geraud, Arthur
    Gazzah, Anas
    Loriot, Yohann
    Hollebecque, Antoine
    Martin-Romano, Patricia
    Ngo-Camus, Maud
    Nicotra, Claudio
    Ponce, Santiago
    Sakkal, Madona
    Caron, Olivier
    Smolenschi, Cristina
    Micol, Jean-Baptiste
    Italiano, Antoine
    Rouleau, Etienne
    Lacroix, Ludovic
    CELLS, 2022, 11 (12)
  • [30] Streamlined next-generation sequencing panel provides comprehensive molecular assessment of mismatch repair deficiency in endometrial and non-serous ovarian cancer
    Tone, A. A.
    Oldfield, L.
    Van de Laar, E.
    Li, T.
    Cirlan, I.
    Vicus, D.
    Clarke, B. A.
    Pugh, T.
    Ferguson, S. E.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 79 - 79
12345